See also this year's filing and all EDGAR filings for this company.
PDF Report 0001423824_2019_ALDER_BIOPHARMACEUTICALS_INC.pdf
Logs
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'REGENERX BIOPHARMACEUTICALS INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001423824')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001423824, ALDER BIOPHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 419,809,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,400,000 |
| 3 | remainder_Assets | 30,000 |
| 4 | LiabilitiesCurrent | 28,236,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 184,272,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 47,474,000 |
| 9 | ResearchAndDevelopmentExpense | 239,108,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -9,847,000 |
| 13 | remainder_ComprehensiveNetIncome | -964,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 426,239,000 |
| 1 | Liabilities | 212,508,000 |
| 2 | Expenses | 286,582,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 213,731,000 |
| 5 | NetIncome | -296,429,000 |
| 6 | ComprehensiveNetIncome | -296,911,000 |
| 7 | BaseVar | 468,070,000 |
| 8 | EconomicCapitalRatio | 0.221 |
Edgar->Model Mapping
Feature Distribution
Change over Time
